# Phase 2 inflammation trials recruiting: 51 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 51 trials in phase 2 for inflammation that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 inflammation trials: 51 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/inflammation

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 51
- Recruiting or not yet: 51
- Read on: November 19, 2026

## Trials

The 25 newest of 51, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 2, 2026 | NCT07911124 | Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease | University of Arkansas | Phase 2 | Recruiting | Chronic Kidney Disease (CKD) | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911124) |
| November 2, 2026 | NCT07908563 | Dupilumab in Major Depressive Disorder | Icahn School of Medicine at Mount Sinai | Phase 2 | Recruiting | Major Depressive Disorder | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908563) |
| October 20, 2026 | NCT07884058 | IGOB131 As A GLP-1 Modulator For Metabolic Disorders In Adults With Obesity | University of Yaounde 1 | Phase 2 | Not yet recruiting | Obesity & Overweight | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884058) |
| September 29, 2026 | NCT07845604 | Precision Depression Adalimumab Trial | Sponsor not shown (see the record) | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845604) |
| September 24, 2026 | NCT07837934 | Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes | Tan Tock Seng Hospital | Phase 2 | Recruiting | Type 2 Diabetes Mellitus (T2DM), Atherosclerosis, Cardiovascular Diseases | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837934) |
| September 10, 2026 | NCT07812792 | Effect of Pentadecanoic Acid Supplementation on Red Blood Cell Health and Biological Aging in Healthy Older Adults | ReCellience15, Inc | Phase 2 | Not yet recruiting | Red Blood Cell Health, Biological Aging, Healthy Aging | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07812792) |
| August 7, 2026 | NCT07753018 | Effects of Curcumin-Piperine Supplementation in Fibromyalgia | Ain Shams University | Phase 2 | Not yet recruiting | Fibromyalgia (FM) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753018) |
| July 21, 2026 | NCT07715864 | Naturally Produced Cannabinoids for Neuroprotection From Concussion | University of Regina | Phase 2 | Recruiting | Healthy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07715864) |
| June 12, 2026 | NCT07646587 | A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius) | Sponsor not shown (see the record) | Phase 2 | Recruiting | COPD (Chronic Obstructive Pulmonary Disease) | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646587) |
| June 8, 2026 | NCT07632872 | Desloratadine as Adjunct Therapy for Rheumatoid Arthritis | Horus University | Phase 2 | Recruiting | Rheumatoid Arthritis (RA), Rheumatoid Arthritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632872) |
| May 27, 2026 | NCT07608796 | JAK Signaling in Depression and Cognition in Male Football Players | Emory University | Phase 2 | Recruiting | Depressive Symptoms, Cognitive Symptom | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07608796) |
| May 22, 2026 | NCT07602166 | Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans | Vanderbilt University Medical Center | Phase 2 | Recruiting | Salt Sensitivity of Blood Pressure, High Blood Pressure, Inflammation, Renin-Angiotensin-Aldosterone System | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602166) |
| May 12, 2026 | NCT07580079 | Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Postprandial Hypoglycemia, End-stage Renal Disease (ESRD), Gastrectomy, Glucose Metabolism Disorders, Inflammation... | 1 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07580079) |
| May 8, 2026 | NCT07575438 | Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults | Sponsor not shown (see the record) | Phase 2 | Recruiting | Type 2 Diabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Prediabetes / Type 2 Diabetes, Obesity &... | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575438) |
| April 16, 2026 | NCT07534332 | Disulfiram in Rheumatoid Arthritis | University of Oklahoma | Phase 2 | Not yet recruiting | Rheumatoid Arthritis, Inflammation, Obesity | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07534332) |
| March 10, 2026 | NCT07461961 | CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock | Brigham and Women's Hospital | Phase 2 | Not yet recruiting | Cardiogenic Shock, Heart Failure, Inflammation | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07461961) |
| December 15, 2025 | NCT07281456 | Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease | National Institute of Dental and Craniofacial Research (NIDCR) | Phase 2 | Recruiting | Sjogren's Syndrome | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07281456) |
| November 28, 2025 | NCT07254000 | Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants | Monash Medical Centre | Phase 2 | Recruiting | Premature Infants, Very Premature Infants, Inflammation | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254000) |
| November 24, 2025 | NCT07245069 | Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients | University Medical Centre Ljubljana | Phase 2 | Recruiting | Heart Failure, Anthracycline-induced Cardiac Toxicity, Endothelial Function (FMD), Arterial Stiffness, Breast Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07245069) |
| September 24, 2025 | NCT07189585 | Inulin Supplementation for Reducing Inflammation and Knee Pain in Older Adults With Osteoarthritis | Yale University | Phase 2 | Not yet recruiting | Knee Osteoarthritis | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07189585) |
| September 5, 2025 | NCT07157735 | A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease | Cambridge University Hospitals NHS Foundation Trust | Phase 2 | Recruiting | Parkinson Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07157735) |
| August 5, 2025 | NCT07104487 | \[18F\]AlF-NOTA-octreotide PET/MRI in Carotid Artery Disease | Universitaire Ziekenhuizen KU Leuven | Phase 2 | Recruiting | Stroke (CVA) or TIA, Carotid Artery Plaque, Atherosclerosis Cardiovascular Disease, Carotid Arteriosclerosis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07104487) |
| July 2, 2025 | NCT07048262 | Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) | CSL Behring | Phase 2 | Recruiting | Non-cystic Fibrosis Bronchiectasis | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07048262) |
| April 15, 2025 | NCT06927739 | Focused Orticumab Research for Treating Inflammation in Coronary Arteries | Abcentra | Phase 2 | Recruiting | Acute Coronary Syndromes, Coronary Arterial Disease (CAD), Inflammation, Heart Disease, Myocardial Infarct... | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06927739) |
| March 20, 2025 | NCT06887062 | Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV) | University of Edinburgh | Phase 2 | Recruiting | Large Vessel Vasculitis, Giant Cell Arteritis (GCA), Takayasu Arteritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06887062) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| China Medical University Hospital | 2 |
| Emory University | 2 |
| Ain Shams University | 2 |
| Monash Medical Centre | 1 |
| University of Wisconsin, La Crosse | 1 |
| ReCellience15, Inc | 1 |
| Medical University of Lublin | 1 |
| Vanderbilt University Medical Center | 1 |
| Washington University School of Medicine | 1 |
| Horus University | 1 |
| Ottawa Hospital Research Institute | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
| [CSL Behring](https://specstream.ai/data/clinical-trials/company/csl-behring) | 1 |
| University of Regina | 1 |
| Abcentra | 1 |
| Montreal Heart Institute | 1 |
| Massachusetts General Hospital | 1 |
| Yale University | 1 |
| University of Edinburgh | 1 |
| University of Oklahoma | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Xijing Hospital | 1 |
| University of Guadalajara | 1 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| University of Arkansas | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 19 |
| Canada | 7 |
| Egypt | 3 |
| United Kingdom | 3 |
| Australia | 2 |
| Poland | 2 |
| Taiwan | 2 |
| Czechia | 2 |
| Italy | 2 |
| Switzerland | 2 |
| Belgium | 2 |
| New Zealand | 1 |
| Argentina | 1 |
| Japan | 1 |
| Hungary | 1 |
| Romania | 1 |
| Spain | 1 |
| Sweden | 1 |
| China | 1 |
| Germany | 1 |
| Singapore | 1 |
| Brazil | 1 |
| Slovenia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Prosthetics providers in the United States](https://specstream.ai/data/businesses/prosthetics-providers/united-states)
- [Genetics practices in the United States](https://specstream.ai/data/businesses/genetics-practices/united-states)
- [B2B newspaper advertising companies in the United States](https://specstream.ai/data/businesses/b2b-newspaper-advertising-companies/united-states)
- [Product design firms in the United States](https://specstream.ai/data/businesses/product-design-firms/united-states)
- [Gastropubs in the United States](https://specstream.ai/data/businesses/gastropubs/united-states)
- [B2B international trade companies in the United States](https://specstream.ai/data/businesses/b2b-international-trade-companies/united-states)
